Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Clinical Trial ID NCT00726596

PubWeight™ 26.84^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00726596

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The double-edged sword of autophagy modulation in cancer.	Clin Cancer Res	2009	5.46
2	Principles and current strategies for targeting autophagy for cancer treatment.	Clin Cancer Res	2011	5.40
3	Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.	Cell Death Dis	2013	2.52
4	Role and regulation of autophagy in cancer.	Biochim Biophys Acta	2009	2.00
5	Autophagy as a therapeutic target in cancer.	Cancer Biol Ther	2011	1.84
6	Autophagy as a target for cancer therapy: new developments.	Cancer Manag Res	2012	1.44
7	Autophagy and endocrine resistance in breast cancer.	Expert Rev Anticancer Ther	2011	1.29
8	Therapeutic targeting of autophagy in disease: biology and pharmacology.	Pharmacol Rev	2013	1.25
9	Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions.	Clin Adv Hematol Oncol	2013	1.22
10	Autophagy in tumor suppression and cancer therapy.	Crit Rev Eukaryot Gene Expr	2011	1.08
11	Tumor suppression and promotion by autophagy.	Biomed Res Int	2014	1.02
12	Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis.	Biores Open Access	2015	0.91
13	Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib.	Autophagy	2014	0.89
14	Chloroquine and hydroxychloroquine for cancer therapy.	Mol Cell Oncol	2014	0.88
15	Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer.	Asian J Androl	2016	0.75